Actuate Therapeutics News and Activities

Actuate Therapeutics is a company listed under the stock ticker ACTU (US).

Acquisition, funding and merger involving Actuate Therapeutics.

• Actuate Therapeutics has filed its IPO. Its stock ticker will be ACTU. (posted on August 14 2024).
• Actuate Therapeutics has just announced a $50 Million fundraising (posted on May 29 2024).

View the org chart displaying its 17 main executives

Most searched biographies at Actuate Therapeutics

• Daniel Schmitt, President, Chief Executive Officer and Director
• Roger Sawhney, Director
• Jason Keyes, Director

Create your alert
to follow the executive moves at Actuate Therapeutics.

Actuate Therapeutics has 2,337 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).
• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (posted on April 30 2025)..
• Deepull has just announced a $50 Million fundraising (posted on April 29 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Kristina Burow - Director at Scholar Rock

Learn more about the Biotechnology industry

Press releases by Actuate Therapeutics

• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• MEDIA | Actuate Therapeutics, Inc.
• News | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCES POSTER PRESENTATIONS AT THE 2024 AACR ANNUAL MEETING | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR  ELRAGLUSIB FOR TREATMENT OF PANCREATIC CANCER | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCESPOSTER PRESENTATIONS AT THE 2023 ASCO ANNUAL MEETING | Actuate Therapeutics, Inc.
• ACTUATE THERAPEUTICS ANNOUNCES POSTER PRESENTATIONS AT THE 2023 AACR ANNUAL MEETING | Actuate Therapeutics, Inc.
• View more press releases Close

Social media about Actuate Therapeutics

• Actuate Therapeutics on Wikipedia, Google News & Yahoo Finance
• Actuate Therapeutics on LinkedIn, Twitter & YouTube